GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sutro Biopharma Inc (FRA:S09) » Definitions » PB Ratio

Sutro Biopharma (FRA:S09) PB Ratio : 0.98 (As of Apr. 07, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Sutro Biopharma PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-07), Sutro Biopharma's share price is €0.505. Sutro Biopharma's Book Value per Share for the quarter that ended in Dec. 2024 was €0.52. Hence, Sutro Biopharma's PB Ratio of today is 0.98.

Good Sign:

Sutro Biopharma Inc stock PB Ratio (=1) is close to 2-year low of 1.

The historical rank and industry rank for Sutro Biopharma's PB Ratio or its related term are showing as below:

FRA:S09' s PB Ratio Range Over the Past 10 Years
Min: 0.82   Med: 1.99   Max: 3.82
Current: 1

During the past 9 years, Sutro Biopharma's highest PB Ratio was 3.82. The lowest was 0.82. And the median was 1.99.

FRA:S09's PB Ratio is ranked better than
74.98% of 1287 companies
in the Biotechnology industry
Industry Median: 2.1 vs FRA:S09: 1.00

During the past 12 months, Sutro Biopharma's average Book Value Per Share Growth Rate was -78.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -53.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -32.80% per year.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Sutro Biopharma was -1.80% per year. The lowest was -53.70% per year. And the median was -17.00% per year.

Back to Basics: PB Ratio


Sutro Biopharma PB Ratio Historical Data

The historical data trend for Sutro Biopharma's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sutro Biopharma PB Ratio Chart

Sutro Biopharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PB Ratio
Get a 7-Day Free Trial Premium Member Only 2.88 2.69 2.03 1.73 3.45

Sutro Biopharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.73 3.50 1.56 2.53 3.45

Competitive Comparison of Sutro Biopharma's PB Ratio

For the Biotechnology subindustry, Sutro Biopharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sutro Biopharma's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sutro Biopharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Sutro Biopharma's PB Ratio falls into.


;
;

Sutro Biopharma PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Sutro Biopharma's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=0.505/0.516
=0.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Sutro Biopharma  (FRA:S09) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Sutro Biopharma PB Ratio Related Terms

Thank you for viewing the detailed overview of Sutro Biopharma's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sutro Biopharma Business Description

Traded in Other Exchanges
Address
111 Oyster Point Boulevard, South San Francisco, CA, USA, 94080
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Sutro Biopharma Headlines

No Headlines